High Potency APIs /HPAPI Market by Type (Generic, Innovative), Synthesis (moAB, Vaccines, Synthetic, Biotech, Recombinant Proteins), Therapy (Glaucoma, Oncology, Hormonal Imbalance), Manufacturer (Captive and Merchant) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: June 2, 2019
Clear
SKU: GMS835 Category:

The global market for HPAPI is expected to reach USD 28.12 billion by 2024, rising at CAGR 8.32% during the forecast period. Growth in this market is driven by factors such as increasing demand for oncology drugs, increasing demand for antibody drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advances in HPAPI manufacturing technologies, and increasing emphasis on precision medicine.

High Potency APIs /HPAPI Market by Type (Generic, Innovative), Synthesis (moAB, Vaccines, Synthetic, Biotech, Recombinant Proteins), Therapy (Glaucoma, Oncology, Hormonal Imbalance), Manufacturer (Captive and Merchant) - 2019 to 2024 1

High Potency APIs /HPAPI Market by Type (Generic, Innovative), Synthesis (moAB, Vaccines, Synthetic, Biotech, Recombinant Proteins), Therapy (Glaucoma, Oncology, Hormonal Imbalance), Manufacturer (Captive and Merchant) - 2019 to 2024 2

High Potency APIs /HPAPI Market by Type (Generic, Innovative), Synthesis (moAB, Vaccines, Synthetic, Biotech, Recombinant Proteins), Therapy (Glaucoma, Oncology, Hormonal Imbalance), Manufacturer (Captive and Merchant) - 2019 to 2024 3

High Potency APIs /HPAPI Market by Type (Generic, Innovative), Synthesis (moAB, Vaccines, Synthetic, Biotech, Recombinant Proteins), Therapy (Glaucoma, Oncology, Hormonal Imbalance), Manufacturer (Captive and Merchant) - 2019 to 2024 4

High Potency APIs /HPAPI Market by Type (Generic, Innovative), Synthesis (moAB, Vaccines, Synthetic, Biotech, Recombinant Proteins), Therapy (Glaucoma, Oncology, Hormonal Imbalance), Manufacturer (Captive and Merchant) - 2019 to 2024 5

High Potency APIs /HPAPI Market by Type (Generic, Innovative), Synthesis (moAB, Vaccines, Synthetic, Biotech, Recombinant Proteins), Therapy (Glaucoma, Oncology, Hormonal Imbalance), Manufacturer (Captive and Merchant) - 2019 to 2024 6

High Potency APIs /HPAPI Market by Type (Generic, Innovative), Synthesis (moAB, Vaccines, Synthetic, Biotech, Recombinant Proteins), Therapy (Glaucoma, Oncology, Hormonal Imbalance), Manufacturer (Captive and Merchant) - 2019 to 2024 7

High Potency APIs /HPAPI Market by Type (Generic, Innovative), Synthesis (moAB, Vaccines, Synthetic, Biotech, Recombinant Proteins), Therapy (Glaucoma, Oncology, Hormonal Imbalance), Manufacturer (Captive and Merchant) - 2019 to 2024 8

1 Global High Potency APIs /HPAPI Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global High Potency APIs /HPAPI Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global High Potency APIs /HPAPI Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global High Potency APIs /HPAPI Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global High Potency APIs /HPAPI Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global High Potency APIs /HPAPI Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global High Potency APIs /HPAPI Market – By Type (Market Size – & million/billion)
8.1 Innovative HPAPI
8.2 Generic HPAPI

9 Global High Potency APIs /HPAPI Market – By Manufacturer
9.1 Captive HPAPI Manufacturers
9.2 Merchant HPAPI Manufacturers

10 Global High Potency APIs /HPAPI Market – By Synthesis
10.1 Synthetic HPAPI Market
10.2 Biotech HPAPI Market

11 Global High Potency APIs /HPAPI Market – By Application
11.1 Oncology
11.2 Hormonal Disorders
11.3 Glaucoma
11.4 Other

12 Global High Potency APIs /HPAPI Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global High Potency APIs /HPAPI Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global High Potency APIs /HPAPI Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Pfizer
14.3 Novartis International Ag
14.4 Boehringer Ingelheim
14.5 Bayer
14.6 Sanofi
14.7 F. Hoffmann-La Roche
14.8 Bristol-Myers Squibb
14.9 Teva Pharmaceutical Industries
14.10 Eli Lilly and Company
14.11 Merck
14.12 Company 11 & more

15 Global High Potency APIs /HPAPI Market – Appendix
15.1 Sources
15.2 Abbreviations